Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 2
1966 2
1967 1
1968 1
1969 1
1970 3
1972 1
1973 2
1974 1
1975 1
1978 2
1979 3
1980 6
1981 5
1982 2
1984 2
1985 1
1986 4
1987 3
1988 6
1989 8
1990 4
1991 2
1993 3
1994 2
1995 5
1996 6
1997 4
1998 4
1999 1
2000 2
2001 2
2002 2
2004 1
2005 3
2006 3
2007 3
2008 4
2009 5
2010 4
2011 5
2012 2
2013 6
2014 9
2015 8
2016 8
2017 5
2018 3
2019 3
2020 1
2021 1
2022 3
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Biomarker signatures for progressive idiopathic pulmonary fibrosis.
Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Clynick B, et al. Among authors: navaratnam v. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. Print 2022 Mar. Eur Respir J. 2022. PMID: 34675050 Free article.
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD Jr, O'Connor GT, Ortega VE, Xu H, Fingerlin TE, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan KT, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LV. Allen RJ, et al. Among authors: navaratnam v. Am J Respir Crit Care Med. 2020 Mar 1;201(5):564-574. doi: 10.1164/rccm.201905-1017OC. Am J Respir Crit Care Med. 2020. PMID: 31710517 Free PMC article.
Neurobiology of Kratom and its main alkaloid mitragynine.
Suhaimi FW, Yusoff NH, Hassan R, Mansor SM, Navaratnam V, Müller CP, Hassan Z. Suhaimi FW, et al. Among authors: navaratnam v. Brain Res Bull. 2016 Sep;126(Pt 1):29-40. doi: 10.1016/j.brainresbull.2016.03.015. Epub 2016 Mar 25. Brain Res Bull. 2016. PMID: 27018165 Review.
ARCHITECT anti-HCV assay.
Myrmel H, Navaratnam V, Asjø B. Myrmel H, et al. Among authors: navaratnam v. J Clin Virol. 2005 Dec;34(4):317. doi: 10.1016/j.jcv.2005.10.003. Epub 2005 Oct 27. J Clin Virol. 2005. PMID: 16257261 No abstract available.
Pharmacokinetics of artemisinin-type compounds.
Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P. Navaratnam V, et al. Clin Pharmacokinet. 2000 Oct;39(4):255-70. doi: 10.2165/00003088-200039040-00002. Clin Pharmacokinet. 2000. PMID: 11069212 Review.
Experimental chemotherapy of lymphatic filariasis. A review.
Mak JW, Navaratnam V, Ramachandran CP. Mak JW, et al. Among authors: navaratnam v. Ann Trop Med Parasitol. 1991 Feb;85(1):131-7. doi: 10.1080/00034983.1991.11812539. Ann Trop Med Parasitol. 1991. PMID: 1888210 Review.
Toxicity testing in the development of anticancer drugs.
Double J, Barrass N, Barnard ND, Navaratnam V. Double J, et al. Among authors: navaratnam v. Lancet Oncol. 2002 Jul;3(7):438-42. doi: 10.1016/s1470-2045(02)00791-x. Lancet Oncol. 2002. PMID: 12142174 Review. No abstract available.
From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction.
Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi FW, Vadivelu R, Vicknasingam BK, Amato D, von Hörsten S, Ismail NI, Jayabalan N, Hazim AI, Mansor SM, Müller CP. Hassan Z, et al. Among authors: navaratnam v. Neurosci Biobehav Rev. 2013 Feb;37(2):138-51. doi: 10.1016/j.neubiorev.2012.11.012. Epub 2012 Dec 1. Neurosci Biobehav Rev. 2013. PMID: 23206666 Review.
163 results